{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:24:45Z","timestamp":1768001085557,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["25293310"],"award-info":[{"award-number":["25293310"]}]},{"name":"JSPS KAKENHI","award":["25462220"],"award-info":[{"award-number":["25462220"]}]},{"name":"JSPS KAKENHI","award":["15K19974"],"award-info":[{"award-number":["15K19974"]}]},{"name":"JSPS KAKENHI","award":["26860567"],"award-info":[{"award-number":["26860567"]}]},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Daiichi-Sankyo Pharmaceutical Co. Ltd."},{"name":"Nippon Boehringer Ingelheim Co. Ltd."},{"name":"Novartis Pharma K.K."},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Co. Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.kint.2018.07.028","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T04:13:49Z","timestamp":1541996029000},"page":"138-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["AT2 receptor stimulation inhibits phosphate-induced vascular calcification"],"prefix":"10.1016","volume":"95","author":[{"given":"Masayoshi","family":"Kukida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Mogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harumi","family":"Kan-no","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Tsukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Yu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-Shuai","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshifumi","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Higaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Juan","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Iwanami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Okura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitsuo","family":"Higaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2018.07.028_bib1","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","article-title":"Worldwide access to treatment for end-stage kidney disease: a systematic review","volume":"385","author":"Liyanage","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2018.07.028_bib2","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2018.07.028_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report","volume":"80","author":"Levey","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.07.028_bib4","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1681\/ASN.2005101101","article-title":"Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease","volume":"17","author":"Norris","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.07.028_bib5","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2018.07.028_bib6","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction","volume":"351","author":"Anavekar","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2018.07.028_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archinte.164.6.659","article-title":"Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization","volume":"164","author":"Keith","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.kint.2018.07.028_bib8","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/hy1001.096358","article-title":"Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease","volume":"38","author":"Blacher","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2018.07.028_bib9","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/ndt\/gfh217","article-title":"A\u00a0simple vascular calcification score predicts cardiovascular risk in haemodialysis patients","volume":"19","author":"Adragao","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.07.028_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/CIRCRESAHA.110.234914","article-title":"Arterial calcification in chronic kidney disease: key roles for calcium and phosphate","volume":"109","author":"Shanahan","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2018.07.028_bib11","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","article-title":"Vascular calcification: pathobiology of a multifaceted disease","volume":"117","author":"Demer","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2018.07.028_bib12","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/CIRCRESAHA.108.183053","article-title":"Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries","volume":"104","author":"Speer","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2018.07.028_bib13","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2174\/157016109789043946","article-title":"Regulation of the sodium-phosphate cotransporter Pit-1 and its role in vascular calcification","volume":"7","author":"Gonzalez","year":"2009","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.kint.2018.07.028_bib14","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1093\/ndt\/gfp137","article-title":"Arterial calcification in patients with chronic kidney disease","volume":"24","author":"Koleganova","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.07.028_bib15","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/01.RES.0000218859.90970.8d","article-title":"Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway","volume":"98","author":"Son","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2018.07.028_bib16","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2018.07.028_bib17","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1053\/j.ajkd.2010.06.011","article-title":"Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD","volume":"56","author":"Kovesdy","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2018.07.028_bib18","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/S0002-9149(01)02321-9","article-title":"The role of the renin-angiotensin system in the development of cardiovascular disease","volume":"89","author":"Unger","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.kint.2018.07.028_bib19","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/01.hjh.0000165623.72310.dd","article-title":"The cardiovascular continuum and renin-angiotensin-aldosterone system blockade","volume":"23","author":"Dzau","year":"2005","journal-title":"J\u00a0Hypertens Suppl"},{"key":"10.1016\/j.kint.2018.07.028_bib20","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/ATVBAHA.112.301099","article-title":"Cross-talk of receptor activator of nuclear factor-kappaB ligand signaling with renin-angiotensin system in vascular calcification","volume":"33","author":"Osako","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2018.07.028_bib21","doi-asserted-by":"crossref","first-page":"917","DOI":"10.5551\/jat.23218","article-title":"Pravastatin and olmesartan synergistically ameliorate renal failure-induced vascular calcification","volume":"21","author":"Iijima","year":"2014","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.kint.2018.07.028_bib22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ajh\/hpv168","article-title":"Angiotensin II type 2 receptor inhibits vascular intimal proliferation with activation of PPARgamma","volume":"29","author":"Kukida","year":"2016","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.kint.2018.07.028_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.yexcr.2015.02.002","article-title":"Phosphate uptake-independent signaling functions of the type III sodium-dependent phosphate transporter, PiT-1, in vascular smooth muscle cells","volume":"333","author":"Chavkin","year":"2015","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.kint.2018.07.028_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048387","article-title":"Direct angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPARgamma activation","volume":"7","author":"Ohshima","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2018.07.028_bib25","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/ndt\/gfi273","article-title":"Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia","volume":"21","author":"Tamagaki","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.07.028_bib26","doi-asserted-by":"crossref","first-page":"5716204","DOI":"10.1155\/2017\/5716204","article-title":"Quercetin attenuates vascular calcification through suppressed oxidative stress in adenine-induced chronic renal failure rats","volume":"2017","author":"Chang","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.kint.2018.07.028_bib27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1159\/000299794","article-title":"Vascular calcification in animal models of CKD: A review","volume":"31","author":"Shobeiri","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2018.07.028_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2369-15-69","article-title":"Mineral bone disorder in chronic kidney disease: head-to-head comparison of the 5\/6 nephrectomy and adenine models","volume":"15","author":"Ferrari","year":"2014","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2018.07.028_bib29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00223-014-9929-5","article-title":"Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model","volume":"96","author":"Yamada","year":"2015","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.kint.2018.07.028_bib30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1161\/ATVBAHA.115.306642","article-title":"Microsomal prostaglandin E synthase-1-derived PGE2 inhibits vascular smooth muscle cell calcification","volume":"36","author":"Gao","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2018.07.028_bib31","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/s41598-017-02351-6","article-title":"Development of a novel chronic kidney disease mouse model to evaluate the progression of hyperphosphatemia and associated mineral bone disease","volume":"7","author":"Tani","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2018.07.028_bib32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1523-1755.2004.00419.x","article-title":"Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy","volume":"65","author":"Fukuda","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.07.028_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2015.11.005","article-title":"A\u00a0novel organ culture model of aorta for vascular calcification","volume":"244","author":"Akiyoshi","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.kint.2018.07.028_bib34","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/01.ASN.0000141960.01035.28","article-title":"Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD","volume":"15","author":"Reynolds","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.07.028_bib35","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20140103","article-title":"Vascular calcification is coupled with phenotypic conversion of vascular smooth muscle cells through Klf5-mediated transactivation of the Runx2 promoter","volume":"34","author":"Zhang","year":"2014","journal-title":"Biosci Rep"},{"key":"10.1016\/j.kint.2018.07.028_bib36","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.3892\/mmr.2014.2449","article-title":"Wnt5a is associated with the differentiation of bone marrow mesenchymal stem cells in vascular calcification by connecting with different receptors","volume":"10","author":"Guan","year":"2014","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.kint.2018.07.028_bib37","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1111\/j.1523-1755.2005.00333.x","article-title":"Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD)","volume":"67","author":"Moe","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.07.028_bib38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tcm.2012.07.020","article-title":"Fetuin-A function in systemic mineral metabolism","volume":"22","author":"Herrmann","year":"2012","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.kint.2018.07.028_bib39","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1161\/ATVBAHA.110.206185","article-title":"Paracrine osteogenic signals via bone morphogenetic protein-2 accelerate the atherosclerotic intimal calcification in\u00a0vivo","volume":"30","author":"Nakagawa","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2018.07.028_bib40","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/stem.1455","article-title":"Osteoblast-targeted suppression of PPARgamma increases osteogenesis through activation of mTOR signaling","volume":"31","author":"Sun","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.kint.2018.07.028_bib41","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/ncomms2087","article-title":"The nuclear hormone receptor PPARgamma counteracts vascular calcification by inhibiting Wnt5a signalling in vascular smooth muscle cells","volume":"3","author":"Woldt","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2018.07.028_bib42","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.yexcr.2016.06.007","article-title":"WNT\/beta-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression","volume":"345","author":"Cai","year":"2016","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.kint.2018.07.028_bib43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bbrc.2016.03.029","article-title":"Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R\/beta catenin pathway","volume":"473","author":"Yu","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.kint.2018.07.028_bib44","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/labinvest.2016.66","article-title":"Deletion of angiotensin II type 2 receptor accelerates adipogenesis in murine mesenchymal stem cells via Wnt10b\/beta-catenin signaling","volume":"96","author":"Matsushita","year":"2016","journal-title":"Lab Invest"},{"key":"10.1016\/j.kint.2018.07.028_bib45","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0006-291X(92)91629-5","article-title":"The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase","volume":"183","author":"Bottari","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.kint.2018.07.028_bib46","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/jcb.21866","article-title":"Involvement of c-Src tyrosine kinase in SHP-1 phosphatase activation by Ang II AT2 receptors in rat fetal tissues","volume":"105","author":"Alvarez","year":"2008","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.kint.2018.07.028_bib47","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4149\/neo_2017_310","article-title":"Activation of the cell membrane angiotensin AT2 receptors in human leiomyosarcoma cells induces differentiation and apoptosis by a PPAR\u03b3-dependent mechanism","volume":"64","author":"L\u00fctzen","year":"2017","journal-title":"Neoplasma"},{"key":"10.1016\/j.kint.2018.07.028_bib48","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jash.2015.06.006","article-title":"Blockade of angiotensin II type 2 receptor by PD123319 inhibits osteogenic differentiation of human mesenchymal stem cells via inhibition of extracellular signal-regulated kinase signaling","volume":"9","author":"Matsushita","year":"2015","journal-title":"J\u00a0Am Soc Hypertens"},{"key":"10.1016\/j.kint.2018.07.028_bib49","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1172\/JCI7886","article-title":"Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation","volume":"104","author":"Tsutsumi","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2018.07.028_bib50","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/377744a0","article-title":"Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice","volume":"377","author":"Hein","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.kint.2018.07.028_bib51","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/ATVBAHA.113.302525","article-title":"Role of local versus systemic vitamin D receptors in vascular calcification","volume":"34","author":"Lomashvili","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2018.07.028_bib52","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1161\/HYPERTENSIONAHA.107.105692","article-title":"Angiotensin II type 2 receptor deletion enhances vascular senescence by methyl methanesulfonate sensitive 2 inhibition","volume":"51","author":"Min","year":"2008","journal-title":"Hypertension"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818306380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818306380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:51:29Z","timestamp":1758761489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253818306380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0085253818306380"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2018.07.028","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AT2 receptor stimulation inhibits phosphate-induced vascular calcification","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2018.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}